The Clorox Company (NYSE:CLX) Shares Sold by First Personal Financial Services

First Personal Financial Services trimmed its position in The Clorox Company (NYSE:CLX) by 5.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 32,056 shares of the company’s stock after selling 1,674 shares during the period. First Personal Financial Services’ holdings in Clorox were worth $5,222,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of the company. Kerusso Capital Management LLC boosted its stake in Clorox by 6.4% in the third quarter. Kerusso Capital Management LLC now owns 19,011 shares of the company’s stock valued at $3,097,000 after acquiring an additional 1,148 shares in the last quarter. Lindbrook Capital LLC raised its holdings in shares of Clorox by 9.9% in the third quarter. Lindbrook Capital LLC now owns 977 shares of the company’s stock worth $159,000 after buying an additional 88 shares during the last quarter. Townsend & Associates Inc raised its holdings in shares of Clorox by 4.0% in the third quarter. Townsend & Associates Inc now owns 11,955 shares of the company’s stock worth $1,901,000 after buying an additional 464 shares during the last quarter. Rovin Capital UT ADV purchased a new position in shares of Clorox in the third quarter worth $393,000. Finally, CWA Asset Management Group LLC purchased a new position in shares of Clorox in the third quarter worth $449,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Up 1.5 %

Shares of NYSE CLX opened at $165.16 on Friday. The company’s 50-day simple moving average is $162.14 and its 200-day simple moving average is $146.83. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $169.09. The firm has a market cap of $20.44 billion, a price-to-earnings ratio of 57.55, a price-to-earnings-growth ratio of 3.01 and a beta of 0.41. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX) last announced its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter last year, the business earned $0.49 earnings per share. The company’s revenue for the quarter was up 27.0% compared to the same quarter last year. Equities analysts predict that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd were given a dividend of $1.22 per share. The ex-dividend date of this dividend was Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 2.95%. Clorox’s payout ratio is presently 170.04%.

Insider Buying and Selling

In related news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.57% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

CLX has been the subject of a number of research analyst reports. Evercore ISI decreased their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. Citigroup raised their target price on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. BNP Paribas raised shares of Clorox to a “strong sell” rating in a report on Friday, September 6th. Deutsche Bank Aktiengesellschaft raised their target price on shares of Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Finally, Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and raised their target price for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. Five investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, Clorox presently has a consensus rating of “Hold” and an average price target of $155.00.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.